Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 198418, 10 pages
http://dx.doi.org/10.1155/2015/198418
Research Article

Intratracheal Bleomycin Aerosolization: The Best Route of Administration for a Scalable and Homogeneous Pulmonary Fibrosis Rat Model?

1Laboratory of Respiratory Physiology, Pathophysiology and Rehabilitation, Research Institute for Health Sciences and Technology, University of Mons, 7000 Mons, Belgium
2Department of Pneumology, Erasme Hospital, 1070 Brussels, Belgium
3Laboratory of Histology, Research Institute for Health Sciences and Technology, University of Mons, 7000 Mons, Belgium

Received 6 October 2014; Accepted 9 January 2015

Academic Editor: Oreste Gualillo

Copyright © 2015 Alexandre Robbe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. V. Woodcock and T. M. Maher, “The treatment of idiopathic pulmonary fibrosis,” F1000Prime Reports, vol. 6, article 16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. J. R. Covvey and E. E. Mancl, “Recent evidence for pharmacological treatment of idiopathic pulmonary fibrosis,” Annals of Pharmacotherapy, vol. 48, no. 12, pp. 1611–1619, 2014. View at Publisher · View at Google Scholar
  3. S. D. Nathan, O. A. Shlobin, N. Weir et al., “Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium,” Chest, vol. 140, no. 1, pp. 221–229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. I. V. Yang, “Epigenomics of idiopathic pulmonary fibrosis,” Epigenomics, vol. 4, no. 2, pp. 195–203, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. C. Kuhn III, J. Boldt, T. E. King Jr., E. Crouch, T. Vartio, and J. A. McDonald, “An immunohistochemical study of architectural remodeling and connective tissue synthesis in pulmonary fibrosis,” American Review of Respiratory Disease, vol. 140, no. 6, pp. 1693–1703, 1989. View at Publisher · View at Google Scholar · View at Scopus
  6. B. B. Moore and C. M. Hogaboam, “Murine models of pulmonary fibrosis,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 294, no. 2, pp. L152–L160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. B. C. Willis, R. M. DuBois, and Z. Borok, “Epithelial origin of myofibroblasts during fibrosis in the lung,” Proceedings of the American Thoracic Society, vol. 3, no. 4, pp. 377–382, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. B. C. Willis, J. M. Liebler, K. Luby-Phelps et al., “Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-β1: potential role in idiopathic pulmonary fibrosis,” The American Journal of Pathology, vol. 166, no. 5, pp. 1321–1332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. K. K. Kim, M. C. Kugler, P. J. Wolters et al., “Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 35, pp. 13180–13185, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. J. W. Lown and S. K. Sim, “The mechanism of the bleomycin-induced cleavage of DNA,” Biochemical and Biophysical Research Communications, vol. 77, no. 4, pp. 1150–1157, 1977. View at Publisher · View at Google Scholar · View at Scopus
  11. E. A. Sausville, J. Peisach, and S. B. Horwitz, “A role for ferrous ion and oxygen in the degradation of DNA by bleomycin,” Biochemical and Biophysical Research Communications, vol. 73, no. 3, pp. 814–822, 1976. View at Publisher · View at Google Scholar · View at Scopus
  12. F. Chua, J. Gauldie, and G. J. Laurent, “Pulmonary fibrosis: searching for model answers,” The American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 1, pp. 9–13, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Kolb, P. J. Margetts, T. Galt et al., “Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 3, pp. 770–777, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. S. N. Giri, D. M. Hyde, and M. A. Hollinger, “Effect of antibody to transforming growth factor β on bleomycin induced accumulation of lung collagen in mice,” Thorax, vol. 48, no. 10, pp. 959–966, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. Q. Wang, Y. Wang, D. M. Hyde et al., “Reduction of bleomycin induced lung fibrosis by transforming growth factor β soluble receptor in hamsters,” Thorax, vol. 54, no. 9, pp. 805–812, 1999. View at Publisher · View at Google Scholar · View at Scopus
  16. R. S. Thrall, J. R. McCormick, R. M. Jack, R. A. McReynolds, and P. A. Ward, “Bleomycin-induced pulmonary fibrosis in the rat. Inhibition by indomethacin,” The American Journal of Pathology, vol. 95, no. 1, pp. 117–130, 1979. View at Google Scholar · View at Scopus
  17. M. A. Mouratis and V. Aidinis, “Modeling pulmonary fibrosis with bleomycin,” Current Opinion in Pulmonary Medicine, vol. 17, no. 5, pp. 355–361, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Limjunyawong, W. Mitzner, and M. R. Horton, “A mouse model of chronic idiopathic pulmonary fibrosis,” Physiological Reports, vol. 2, no. 2, Article ID e00249, 2014. View at Publisher · View at Google Scholar
  19. R. Peng, S. Sridhar, G. Tyagi et al., “Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for ‘active’ disease,” PLoS ONE, vol. 8, no. 4, Article ID e59348, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. K. E. Driscoll, D. L. Costa, G. Hatch et al., “Intratracheal instillation as an exposure technique for the evaluation of respiratory tract toxicity: uses and limitations,” Toxicological Sciences, vol. 55, no. 1, pp. 24–35, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. P. Vogel, V. R. Rivera, M. L. M. Pitt, and M. A. Poli, “Comparison of the pulmonary distribution and efficacy of antibodies given to mice by intratracheal instillation or aerosol inhalation,” Laboratory Animal Science, vol. 46, no. 5, pp. 516–523, 1996. View at Google Scholar · View at Scopus
  22. D. Vansthertem, A. Gossiaux, A.-E. Declèves et al., “Expression of nestin, vimentin, and NCAM by renal interstitial cells after ischemic tubular injury,” Journal of Biomedicine and Biotechnology, vol. 2010, Article ID 193259, 10 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. R.-H. Hübner, W. Gitter, N. E. El Mokhtari et al., “Standardized quantification of pulmonary fibrosis in histological samples,” BioTechniques, vol. 44, no. 4, pp. 507–517, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. J. D. Williamson, L. R. Sadofsky, and S. P. Hart, “The pathogenesis of bleomycin-induced lung injury in animals and its applicability to human idiopathic pulmonary fibrosis,” Experimental Lung Research, 2014. View at Publisher · View at Google Scholar
  25. S. H. Phan, “The myofibroblast in pulmonary fibrosis,” Chest, vol. 122, pp. 286S–289S, 2002. View at Google Scholar · View at Scopus
  26. A. Günther, N. Lübke, M. Ermert et al., “Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits,” The American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 11, pp. 1358–1365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. W. M. Foster, D. M. Walters, M. Longphre, K. Macri, and L. M. Miller, “Methodology for the measurement of mucociliary function in the mouse by scintigraphy,” Journal of Applied Physiology, vol. 90, no. 3, pp. 1111–1117, 2001. View at Google Scholar · View at Scopus
  28. V. de Vooght, J. A. J. Vanoirbeek, S. Haenen, E. Verbeken, B. Nemery, and P. H. M. Hoet, “Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma,” Toxicology, vol. 259, no. 1-2, pp. 84–89, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. D. M. Walters and S. R. Kleeberger, “Mouse models of bleomycin-induced pulmonary fibrosis,” in Current Protocols in Pharmacology, chapter 5:unit 5.46, 2008. View at Publisher · View at Google Scholar
  30. C. Egger, C. Cannet, C. Gérard et al., “Administration of bleomycin via the oropharyngeal aspiration route leads to sustained lung fibrosis in mice and rats as quantified by UTE-MRI and histology,” PLoS ONE, vol. 8, no. 5, Article ID e63432, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. R. Lizio, A. Westhof, C.-M. Lehr, and T. Klenner, “Oral endotracheal intubation of rats for intratracheal instillation and aerosol drug delivery,” Laboratory Animals, vol. 35, no. 3, pp. 257–260, 2001. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Lizio, D. Marx, T. Nolte et al., “Development of a new aerosol delivery system for systemic pulmonary delivery in anaesthetized and orotracheal intubated rats,” Laboratory Animals, vol. 35, no. 3, pp. 261–270, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Bivas-Benita, R. Zwier, H. E. Junginger, and G. Borchard, “Non-invasive pulmonary aerosol delivery in mice by the endotracheal route,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 61, no. 3, pp. 214–218, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. J. E. Phillips, R. Peng, L. Burns et al., “Bleomycin induced lung fibrosis increases work of breathing in the mouse,” Pulmonary Pharmacology and Therapeutics, vol. 25, no. 4, pp. 281–285, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A. G. Rosas-Taraco, D. M. Higgins, J. Sánchez-Campillo, E. J. Lee, I. M. Orme, and M. González-Juarrero, “Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis,” The American Journal of Respiratory Cell and Molecular Biology, vol. 41, no. 2, pp. 136–145, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. A. G. Rosas-Taraco, D. M. Higgins, J. Sánchez-Campillo, E. J. Lee, I. M. Orme, and M. González-Juarrero, “Local pulmonary immunotherapy with siRNA targeting TGFβ1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice,” Tuberculosis, vol. 91, no. 1, pp. 98–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Gazdhar, I. Grad, L. Tamò, M. Gugger, A. Feki, and T. Geiser, “The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor,” Stem Cell Research & Therapy, vol. 5, article 123, 2014. View at Publisher · View at Google Scholar
  38. Q. Ye, Y. Li, H. Jiang et al., “Prevention of pulmonary fibrosis via trichostatin A (TSA) in bleomycin induced rats,” Sarcoidosis, Vasculitis and Diffuse Lung Diseases, vol. 31, pp. 219–226, 2014. View at Google Scholar
  39. Z. I. Cleveland, R. S. Virgincar, Y. Qi, S. H. Robertson, S. Degan, and B. Driehuys, “3D MRI of impaired hyperpolarized 129Xe uptake in a rat model of pulmonary fibrosis,” NMR in Biomedicine, vol. 27, no. 12, pp. 1502–1514, 2014. View at Publisher · View at Google Scholar